BNP PARIBAS FINANCIAL MARKETS - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 56 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$124,028
+187.2%
16,515
+237.7%
0.00%
Q2 2023$43,188
+2954.3%
4,891
+2777.1%
0.00%
Q1 2023$1,414
-13.4%
1700.0%0.00%
Q4 2022$1,632
-99.9%
1700.0%0.00%
Q3 2022$1,377,000
+45.1%
1700.0%0.00%
Q2 2022$949,000
-95.1%
170
-95.1%
0.00%
Q1 2022$19,354,000
+1795.6%
3,456
+1389.7%
0.00%
Q4 2021$1,021,000
-57.7%
232
-9.4%
0.00%
Q3 2021$2,412,000
-13.8%
256
-33.3%
0.00%
Q2 2021$2,799,000
-83.9%
384
-86.3%
0.00%
Q1 2021$17,363,000
-44.7%
2,796
-33.7%
0.00%
Q4 2020$31,409,000
-0.6%
4,216
-19.1%
0.00%
Q3 2020$31,591,000
+367.7%
5,213
+544.4%
0.00%
Q2 2020$6,755,000
+1735.6%
809
+1204.8%
0.00%
Q1 2020$368,000
-8.5%
620.0%0.00%
Q4 2019$402,000
-94.1%
62
-95.6%
0.00%
Q3 2019$6,811,000
+20.3%
1,4160.0%0.00%
Q2 2019$5,664,000
-56.1%
1,416
-46.8%
0.00%
Q1 2019$12,901,000
+937.1%
2,660
+1264.1%
0.00%
Q4 2018$1,244,000
-59.0%
195
-47.3%
0.00%
Q3 2018$3,034,000
-21.5%
3700.0%0.00%
Q2 2018$3,863,0003700.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Sonic GP LLC 2,407,357$18,079,25117.55%
Solas Capital Management, LLC 1,725,567$12,959,0089.07%
DG Capital Management, LLC 1,143,099$8,584,6734.70%
HARBERT FUND ADVISORS, INC. 466,869$3,506,1862.56%
AIGH Capital Management LLC 373,526$2,805,1801.33%
Southpoint Capital Advisors LP 4,077,214$30,619,8770.68%
APIS CAPITAL ADVISORS, LLC 70,000$525,7000.68%
Worth Venture Partners, LLC 92,636$695,6960.41%
Lion Point Capital, LP 110,000$826,1000.37%
683 Capital Management, LLC 300,000$2,253,0000.18%
View complete list of FENNEC PHARMACEUTICALS INC shareholders